Home / Small molecules / Drug product / High Potency Drug Product

High Potency Drug Product

High Potency Drug Product

WuXi STA’s high potency drug product capabilities are delivered as part of an integrated CMC platform that connects API development, analytical control, and drug product manufacturing within a unified containment and quality framework. This integrated approach is designed to minimize handling and transfer risk, maintain consistent exposure and impurity control, and support reliable progression from preclinical development through commercial manufacturing.

High Potency Oral Solid Dosage Forms (OSD)

Tablets and capsules manufactured under high-containment conditions
Wet and dry granulation, tableting, encapsulation, and coating
End-to-end processing within contained systems to minimize operator exposure and material transfer
1.1 billion doses annual capacity
OEL control to 10 ng/m³

High Potency Injectables

Liquid filling and lyophilization for toxic and highly potent compounds
Support for ADCs and PDCs
25 million vials annual capacity
High-containment fill–finish lines with WIP (wash-in-place) and external vial washing to reduce cross-contamination risk
OEL control to 10 ng/m³

Get in touch

Our quality

Quality is woven into every step of our clinical trial supply services. From GMP-certified packaging and labeling to secure storage and precise distribution, we ensure your investigational products meet the highest global standards.

No detail is overlooked – our dedicated teams uphold rigorous quality controls and clear documentation to protect your study’s success. With us, you can trust that every shipment moves with unwavering care, compliance, and a commitment to patient safety.

Regulatory dossier prep

Our history

From its foundation, our journey has been defined by a commitment to innovation, quality, and strong partnerships, driven by a purpose-driven pace.

We’ve evolved into a leading CRDMO with a perfectly orchestrated platform, consistently expanding our global footprint and capabilities to accelerate breakthroughs for our partners and patients worldwide.

Learn more